Dr. Sturge Simon
Simon is one of the most successful and seasoned biotech CEOs in the UK, and was voted CEO of the year by his peers in 2005. Simon has built a very strong reputation not only in the industry but also in the investment community. His experience includes eight years at Celltech (now owned by Lonza), and Dr. Sturge was the founder and CEO of RiboTargets, later reversed into Vernalis Plc. After serving as CEO of OctoPlus N.V. for two years, he most recently was Senior Vice President of Boehringer Ingelheim’s Biopharmaceutical Business. At present, he is Chief Operating Officer of Merck Serono. He is also a regular speaker at conferences including the World Economic Forum. Dr. Sturge holds a BSc degree in biology from the University of Sussex in the UK.